Net Profit Margins
Genmab A/S’s revenue jumped 171.56% since last year same period to $681.01Mn in the Q1 2018. On a quarterly growth basis, Genmab A/S has generated -33.09% fall in its revenue since last 3-months.
Genmab A/S’s net profit jumped 1133.46% since last year same period to $198.57Mn in the Q1 2018. On a quarterly growth basis, Genmab A/S has generated -74.73% fall in its net profits since last 3-months.
Genmab A/S’s net profit margin jumped 354.21% since last year same period to 29.16% in the Q1 2018. On a quarterly growth basis, Genmab A/S has generated -62.23% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter
EPS Estimate Current Year
Genmab A/S’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a -64.13% fall from last quarter’s estimates.
Genmab A/S’s earning per share (EPS) estimates for the current year stand at 0.13.
Earning Per Share (EPS)
Genmab A/S’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2023. This indicates that the Genmab A/S has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
|Earnings Date||Estimated EPS||Reported EPS||Surprise %|
Kalvebod Brygge 43, Copenhagen, Denmark, 1560
Jan van de Winkel
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*